88 related articles for article (PubMed ID: 23827153)
1. Bioinformatics analysis of breast cancer bone metastasis related gene-CXCR4.
Zhang HW; Sun XF; He YN; Li JT; Guo XH; Liu H
Asian Pac J Trop Med; 2013 Sep; 6(9):732-8. PubMed ID: 23827153
[TBL] [Abstract][Full Text] [Related]
2. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of CXCR4 in breast cancer is associated with early distant and bone metastases.
Hung CS; Su HY; Liang HH; Lai CW; Chang YC; Ho YS; Wu CH; Ho JD; Wei PL; Chang YJ
Tumour Biol; 2014 Feb; 35(2):1581-8. PubMed ID: 24101191
[TBL] [Abstract][Full Text] [Related]
4. An isoform of C/EBPβ, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migration.
Park BH; Kook S; Lee S; Jeong JH; Brufsky A; Lee BC
J Biol Chem; 2013 Oct; 288(40):28656-67. PubMed ID: 23966000
[TBL] [Abstract][Full Text] [Related]
5. ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling.
Masuda T; Endo M; Yamamoto Y; Odagiri H; Kadomatsu T; Nakamura T; Tanoue H; Ito H; Yugami M; Miyata K; Morinaga J; Horiguchi H; Motokawa I; Terada K; Morioka MS; Manabe I; Iwase H; Mizuta H; Oike Y
Sci Rep; 2015 Mar; 5():9170. PubMed ID: 25773070
[TBL] [Abstract][Full Text] [Related]
6. High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome.
Chu QD; Panu L; Holm NT; Li BD; Johnson LW; Zhang S
J Surg Res; 2010 Apr; 159(2):689-95. PubMed ID: 19500800
[TBL] [Abstract][Full Text] [Related]
7. Pomolic Acid Inhibits Invasion of Breast Cancer Cells Through the Suppression of CXC Chemokine Receptor Type 4 Expression.
Kim B; Kim JH; Park B
J Cell Biochem; 2016 Jun; 117(6):1296-307. PubMed ID: 26495998
[TBL] [Abstract][Full Text] [Related]
8. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
[TBL] [Abstract][Full Text] [Related]
10. Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4(+) migrating cancer stem cells.
Mukherjee S; Manna A; Bhattacharjee P; Mazumdar M; Saha S; Chakraborty S; Guha D; Adhikary A; Jana D; Gorain M; Mukherjee SA; Kundu GC; Sarkar DK; Das T
Oncogene; 2016 Sep; 35(37):4937-48. PubMed ID: 26923331
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.
Lapteva N; Yang AG; Sanders DE; Strube RW; Chen SY
Cancer Gene Ther; 2005 Jan; 12(1):84-9. PubMed ID: 15472715
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
14. Comparative role of acetylation along c-SRC/ETS1 signaling pathway in bone metastatic and invasive mammary cell phenotypes.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Biochim Biophys Acta; 2011 Oct; 1813(10):1767-76. PubMed ID: 21741415
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic Knockout of CXCR4 Expression by a Novel Intrakine Mutant hSDF-1α/54/KDEL Inhibits Breast Cancer Metastasis.
Chen HY; Clayman ES; Ma WF
J Interferon Cytokine Res; 2015 Oct; 35(10):771-8. PubMed ID: 25978539
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N
J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395
[TBL] [Abstract][Full Text] [Related]
17. Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9.
Baek SH; Kim SM; Nam D; Lee JH; Ahn KS; Choi SH; Kim SH; Shim BS; Chang IM; Ahn KS
Pharm Biol; 2012 Oct; 50(10):1210-8. PubMed ID: 22853317
[TBL] [Abstract][Full Text] [Related]
18. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.
Woo SU; Bae JW; Kim CH; Lee JB; Koo BW
Ann Surg Oncol; 2008 Jan; 15(1):281-5. PubMed ID: 17763975
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 expression in early breast cancer and risk of distant recurrence.
Andre F; Xia W; Conforti R; Wei Y; Boulet T; Tomasic G; Spielmann M; Zoubir M; Berrada N; Arriagada R; Hortobagyi GN; Hung MC; Pusztai L; Delaloge S; Michiels S; Cristofanilli M
Oncologist; 2009 Dec; 14(12):1182-8. PubMed ID: 19939894
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic molecular classification of breast cancers based on gene expression profiling].
Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
